Zepbound, FDA-approved for obstructive sleep apnea and obesity, is part of the GLP-1 drug class showing promise in addressing conditions like cognitive decline, addiction, and cardiovascular risks, though they also carry side effects.
Read More
Only 1% of Australians with insomnia access CBT-I, according to Flinders University researchers who are calling for changes to improve access to this proven non-drug treatment.
Read More
The prevalence increased threefold in adolescents and increased fivefold in young adults from 2001 to 2019.
Read More
Hilton is partnering with Calm, a sleep and relaxation app, to offer guests access to mindfulness tools, guided meditations, and sleep content through its Connected Room technology.
Read More
A new red light therapy trend report reveals UAE residents are using the technology to address sleep issues, skin concerns, and overall wellness.
Read More